Abstract
Background: The addition of 18F-FDG PET to the standard work-up of patients with LABC may lead to the detection of unexpected distant metastases of which skeleton is the most common site. 18F-FDG has limitations in detecting osteoblastic malignant skeletal lesions. Bone scintigraphy (with 99mTc-MDP of 18F-NaF) is the routine imaging modality for the diagnosis of osteoblastic skeletal metastases. We combined both the 18F-FDG and 18F-NaF PET/CT into a single study to examine its role in detecting skeletal metastases.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
